Longduoduo Company Limited Reports 64% Revenue Decline and Significant Net Loss in Latest Filing

Longduoduo Company Limited reported significant financial challenges in its latest 10-Q filing for the nine months ending March 31, 2026. The company generated total revenue of $1.19 million, a decrease of approximately 64% compared to $3.32 million for the same period in 2025. The decline was primarily driven by a substantial drop in commission revenue, which fell to $1.18 million from $3.20 million year-over-year. Service revenue also saw a sharp decline, dropping to $1,350 from $28,724 in the previous year. The company recorded a net loss of $575,434, compared to a net income of $325,775 in the prior year, reflecting a significant shift in profitability.

In terms of operational metrics, Longduoduo's total assets decreased to $1.75 million as of March 31, 2026, down from $2.13 million at the end of June 2025. Current liabilities increased to $932,776, compared to $830,464 in the previous fiscal period. The company's accumulated deficit also widened to $6.68 million from $6.17 million. The decline in cash and cash equivalents was notable, with the balance falling to $1.22 million from $1.64 million over the same period. The company attributed these changes to a combination of reduced revenue streams and increased operational costs.

Strategically, Longduoduo has been focusing on expanding its healthcare service offerings. The company began engaging in agent sales of preventive healthcare solutions in June 2023, which is expected to diversify its revenue sources. However, the impact of this strategic shift has yet to be reflected positively in the financial results. The company also underwent a reverse stock split in September 2023, which was aimed at improving its stock price and market perception.

Longduoduo's customer concentration remains high, with one customer accounting for 99.1% of its revenue for the nine months ended March 31, 2026. This reliance on a single customer poses a risk to revenue stability. The company has also reported fluctuations in foreign currency translation adjustments, which contributed to its comprehensive loss of $504,512 for the nine-month period. The company’s employee headcount and user engagement metrics were not disclosed in the filing, limiting insights into operational efficiency and market penetration.

Looking ahead, Longduoduo's management has indicated a commitment to enhancing its service offerings and expanding its market presence. However, the company faces significant challenges, including the need to diversify its customer base and improve its financial performance. The outlook remains cautious as the company navigates a competitive healthcare landscape while addressing its operational and financial hurdles.